ProsCan for Men: Randomised controlled trial of a decision support intervention for men with localised prostate cancer
2008

ProsCan for Men: A Study on Decision Support for Prostate Cancer

Sample size: 700 publication Evidence: moderate

Author Information

Author(s): Suzanne K Chambers, Megan Ferguson, RA Gardiner, David Nicol, Louisa Gordon, Stefano Occhipinti, Joanne Aitken

Primary Institution: Viertel Centre for Research in Cancer Control, Cancer Council Queensland

Hypothesis

Men who receive the intervention will have better psychosocial outcomes compared to those receiving usual care.

Conclusion

The study aims to improve decision-making and long-term adjustment for men with localized prostate cancer through a decision support intervention.

Supporting Evidence

  • Prostate cancer is the most common male cancer in the Western world.
  • Decision-related distress is common for men after diagnosis.
  • Many men prefer active involvement in their treatment decisions.

Takeaway

This study is trying to help men with prostate cancer make better decisions about their treatment and feel better afterwards.

Methodology

700 men were recruited and randomized to receive either a decision support intervention or usual care, with assessments at multiple time points.

Limitations

The study may not generalize to all men with prostate cancer due to specific inclusion criteria.

Participant Demographics

Men newly diagnosed with localized prostate cancer, able to read and speak English, with no previous history of head injury, dementia, or psychiatric illness.

Digital Object Identifier (DOI)

10.1186/1471-2407-8-207

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication